Get started
Author

Marina Pagnuzzi

Observed names: M Pagnuzzi, Marina Pagnuzzi-Boncompagni, Pagnuzzi, Marina
Observed institution: Scientific Centre of Monaco
ORCID: 0009-0001-2060-4122
Observed ORCID: 0009-0001-2060-4122
OpenAlex ID: A5025567335
VEGFC negatively regulates the growth and aggressiveness of medulloblastoma cells
2020 · Manon Penco-Campillo, Yannick Comoglio, et al. · Communications Biology · 19
PDF
Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al. · Cancer Research Communications · 9
Author Correction: VEGFC negatively regulates the growth and aggressiveness of medulloblastoma cells
2020 · Manon Penco-Campillo, Yannick Comoglio, et al. · Communications Biology · 2
PDF
MMRi62 induces iron depletion–driven apoptosis through a ferritin-independent mechanism
2026 · F Segui, M Pagnuzzi, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Deletion of Ferritin Heavy Chain Limits Tumor Growth and Promotes Iron-Dependent Stress in Medulloblastoma
2026 · Fabien Segui, Jerome Durivault, et al. · SSRN Electronic Journal
Figure S6 from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
PDF
FIGURE 3 from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
FIGURE 6 from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
FIGURE 4 from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
Figure S2 from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
FIGURE 1 from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
Data from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
FIGURE 2 from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
Figure S5 from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
PDF
Data from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
FIGURE 5 from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
Figure S4 from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
Table S1 from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
PDF
Figure S8 from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
Figure S3 from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
Figure S7 from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
PDF
Figure S1 from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
PDF
Figure S7 from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
Erratum: Author Correction: VEGFC negatively regulates the growth and aggressiveness of medulloblastoma cells (Communications biology (2020) 3 1 (579))
2020 · Manon Penco-Campillo, Yannick Comoglio, et al. · Newcastle University ePrints (Newcastle Univesity)
Unexpected Effects of Photontherapy and Protontherapy on VEGFC Production and Tumor Aggressiveness in Different Medulloblastoma Subgroups
2019 · Comoglio, Yannick, Javier, Alvaro, et al. · HAL
PDF
Works count: 27
Citation count: 30
H-index: 2
I10-index: 1
Year
Topic
Type